Abstract
Metastasis is the major concern in the management of cancer (1). While standard chemotherapy has shown promise in the treatment of certain kinds of tumors, its utility has been limited due to toxicity to normal cells (2–3). Recent advances in experimental immunobiology, tumor immunology and cancer metastasis have increased our knowledge concerning the host’s immune response to tumors and the regulation of tumor growth (4–5). These advances have also initiated new approaches in the diagnosis and treatment of cancer (6).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zeidman, I. 1981. Metastasis, an overview, p. 1–28. In J. Marchalonis, M. Hanna and I. Fidler (eds.), Cancer Biology Vol. 2. Marcel Dekker, New York.
Clarysse, A. M., W. J. Cathey, G. E. Cartwright et al. 1969. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 209: 1861–1864.
Anderson, E. E., 0. E. Cobb, J. F. Glenn. 1967. Cyclophosphamide hemorrhagic cystitis. J. Urol. 97: 857–858.
Poste, G. and I. J. Fidler. 1980. The pathogenesis of cancer metastasis. Nature 283: 139–146.
Hersh, E. M., J. U. Gutterman and G. M. Mavligit. 1975. Cancer and host defense mechanisms. In H. L. Ioachin (ed.), Pathobiology annual. Academic Press, New York.
Wright, P. W. and I. D. Bernstein. 1980. Serotherapy of malignant disease Prog. Exp. Tumor Res. 25: 140.
Lausch, R. N. and F. Rapp. 1974. Tumor specific antigens and re-expression of fetal antigens in mammalian cells. Prog. Exp. Tumor Res. 19: 45.
Thomson, D. M. P. 1975. Soluble tumour-specific antigen and its relationship to tumour growth. Intl. J. Cancer 15: 1016.
Ritz, J., J. M. Pesando, J. Notis McConasty, L. A. Clavell, S. E. Sallan and S. F. Schlossman. 1981. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res. 41: 4771–4775.
Kirch, M. E. and U. Hammerling. 1981. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells. J. Immunol. 127: 805–810.
Israels, L. G. and J. H. Linford. 1963. Binding of chlorambucil to proteins, p. 399. In Proceedings of the fifth Canadian cancer research conference. Academic Press, New York.
Krishan, A. 1975. Rapid flow cytofluoreometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66: 188–193.
Barlogie, B., B. Drewinko, D. A. Johnston et al. 1976. Pulse cytophotometric analysis of synchronized cells in vitro. Cancer Res. 36: 1176–1181.
Bernstein, I.D. et al. 1980. Monoclonal antibody therapy of mouse leukemia, p. 275–291. In R. H. Kennet, T. J. McKearn and K. B. Bechtol (eds.), Monoclonal antibodies. Hybridomas: a new dimension in biological analysis. Plenum Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Feinerman, B., Paul, R.D., Feinerman, G. (1983). Treatment of a Murine Leukemia with Chlorambucil Bound Monoclonal Antibodies. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1410-4_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1412-8
Online ISBN: 978-1-4757-1410-4
eBook Packages: Springer Book Archive